Send the following on WhatsApp
Continue to ChatNovavax 2019 冠狀病毒病疫苗 Nuvaxovid (TM)獲人用醫藥產品委員會 (CHMP) 建議在歐盟的有條件上市授權擴展至 12 至 17 歲青少年 https://geneonline.news/novavax-2019-%e5%86%a0%e7%8b%80%e7%97%85%e6%af%92%e7%97%85%e7%96%ab%e8%8b%97-nuvaxovid-tm%e7%8d%b2%e4%ba%ba%e7%94%a8%e9%86%ab%e8%97%a5%e7%94%a2%e5%93%81%e5%a7%94%e5%93%a1%e6%9c%83-chmp-%e5%bb%ba/